UNIVERSITY OF SOUTH FLORIDA

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 29553
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 108101
 
 
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 87153
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 7790
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 7156
 
 
 
C07D HETEROCYCLIC COMPOUNDS 52110
 
 
 
C07K PEPTIDES 4789
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 4452
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 4356
 
 
 
H01L SEMICONDUCTOR DEVICES; ELECTRIC SOLID STATE DEVICES NOT OTHERWISE PROVIDED FOR 39323

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0042,968 HUMAN CORD BLOOD AS A SOURCE OF NEURAL TISSUE REPAIR OF THE BRAIN AND SPINAL CORDOct 23, 17Feb 15, 18[A61K]
2018/0036,529 SYSTEM AND METHOD FOR ELECTROPORATION CONTROLLED BY ELECTRICAL IMPEDANCE MEASUREMENTSSep 29, 17Feb 08, 18[A61N]
2018/0014,866 BONE FUSION SYSTEMSep 28, 17Jan 18, 18[A61B, A61F]
2018/0008,564 Method of Treating Colorectal Cancers Using a PKC InhibitorJul 06, 17Jan 11, 18[C12Q, G01N, A61K]
2018/0000,761 Methods for Making Catechin DerivativesDec 12, 16Jan 04, 18[C07D, A61K]
2018/0001,298 METAL OXIDE-BASED BIOCOMPATIBLE HYBRID SORBENT FOR THE EXTRACTION AND ENRICHMENT OF CATECHOLAMINE NEUROTRANSMITTERS AND RELATED COMPOUNDS, AND METHOD OF SYNTHESISJun 30, 17Jan 04, 18[B01J, G01N, B01D]
2018/0002,413 INFLAMMATORY DISEASE DIAGNOSIS AND METHODS OF TREATMENT USING LIPOPOLYSACCHARIDE-RESPONSIVE BEIGE-LIKE ANCHORJul 27, 17Jan 04, 18[C12N, A61K, C07K]
2018/0002,706 METHODS AND COMPOSITIONS FOR CLONING INTO LARGE VECTORSDec 18, 15Jan 04, 18[C12N]
2017/0348,336 METHOD OF TREATING MELANOMA USING AN INHIBITOR OF AN ATYPICAL PROTEIN KINASE CJun 02, 17Dec 07, 17[C12Q, G01N, A61K]
2017/0328,900 METHODS AND MATERIALS FOR CAPTURE ANTIBODY TARGETED FLUORESCENT IN-SITU HYBRIDIZATION (CAT-FISH)Jul 24, 17Nov 16, 17[G01N]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9923650 Compact dual-channel transceiversSep 27, 16Mar 20, 18[H04B]
9911540 Piezoelectric-based solar cellsAug 17, 16Mar 06, 18[H01G, H01L]
9901374 Laparoscopic tool with obturatorJun 16, 15Feb 27, 18[A61B]
9896668 Substrate-mimetic AKT inhibitorAug 30, 16Feb 20, 18[C12N, C07D, C07C, A61K, C07K]
9889221 Enhancement of photocatalytic effect with surface roughness in photocatalytic reactorsOct 10, 14Feb 13, 18[A61L, F24F, F15D]
9893529 Coupling dynamics for power systems with iterative discrete decision making architecturesJun 29, 16Feb 13, 18[H02J]
9877668 Orientation invariant gait matchingNov 18, 15Jan 30, 18[A61B]
9877739 Power morcellation in a protected environmentApr 17, 15Jan 30, 18[A61B]
9879166 Encapsulation of thermal energy storage mediaJun 16, 15Jan 30, 18[C09K, F28D]
9872849 Diterpenoid membranolide compounds having anti-leishmania activity and uses thereofJul 28, 15Jan 23, 18[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0188,554 ANIMAL MODEL FOR STUDYING COMPLEX HUMAN DISEASESAbandonedApr 18, 16Jul 06, 17[C12N, A01K, G01N]
2017/0181,983 EXO-S-MECAMYLAMINE FORMULATION AND USE IN TREATMENTAbandonedMar 13, 17Jun 29, 17[A61K]
2017/0143,769 HUMAN UMBILICAL CORD BLOOD-DERIVED MONOCYTES FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND DISORDERSAbandonedNov 23, 16May 25, 17[A61K]
2017/0140,672 RADIAL ARM MODEL WITH MESHAbandonedNov 14, 16May 18, 17[G09B]
2017/0106,019 COMPOSITIONS AND METHODS FOR MITIGATING DRUG RESISTANT BACTERIAAbandonedOct 20, 16Apr 20, 17[A61K]
2017/0080,007 EFFECTIVE TREATMENT OF ESOPHAGEAL ADENOCARCINOMA USING TRICIRIBINE AND RELATED COMPOUNDSAbandonedAug 30, 16Mar 23, 17[A61K]
2017/0050,946 ANTIMICROBIALS FROM AN EPIGENETICS BASED FUNGAL METABOLITE SCREENING PROGRAMAbandonedJul 27, 16Feb 23, 17[C07D, C12P]
2017/0022,540 BIOINK FOR THREE-DIMENSIONAL BIOMATERIAL PRINTINGAbandonedJul 25, 16Jan 26, 17[C12N, C09D, C12Q]
2017/0000,630 Universal Multi-Branch EndograftAbandonedJun 30, 15Jan 05, 17[A61F]
2016/0354,227 CUSTOM REDUCTION SPLINT FOR EDENTULOUS PATIENTSAbandonedAug 23, 16Dec 08, 16[A61M, G06T, A61C, A61B, A61F]
2016/0338,682 PNEUMATIC SYSTEM AND METHOD FOR INTERMITTENTLY RIGIDIFYING AN ENDOSCOPIC SPECIMEN RETAINING CARRIERAbandonedMay 23, 16Nov 24, 16[A61B]
2016/0335,223 METHODS AND SYSTEMS FOR COMPUTATION OF BILEVEL MIXED INTEGER PROGRAMMING PROBLEMSAbandonedMay 26, 15Nov 17, 16[G06F]
2016/0317,487 METHODS OF SUSTAINING DIETARY KETOSIS AND ITS EFFECTS ON LIPID PROFILEAbandonedJul 11, 16Nov 03, 16[A61K]
2016/0280,714 POLYHEDRAL CAGE-CONTAINING METALLOPORPHYRIN FRAMEWORKS, METHODS OF MAKING, AND METHODS OF USINGAbandonedApr 22, 16Sep 29, 16[C07D]
2016/0160,274 MATERIALS AND METHODS FOR PROFILING MICRORNASAbandonedDec 08, 15Jun 09, 16[C12Q]
2016/0153,977 NOVEL GOLD NANOPARTICLE AGGREGATES AND THEIR APPLICATIONSAbandonedFeb 08, 16Jun 02, 16[G01N]
2016/0068,503 (-)-EPIGALLOCATECHIN GALLATE DERIVATIVES FOR INHIBITING PROTEASOMEAbandonedSep 15, 15Mar 10, 16[C07D]
2016/0053,319 MICRO-RNAS MODULATING IMMUNITY AND INFLAMMATIONAbandonedJun 23, 15Feb 25, 16[C12N, C12Q]
2016/0030,483 MATERIALS AND METHODS FOR TREATING ALLERGIC AND INFLAMMATORY CONDITIONSAbandonedAug 07, 15Feb 04, 16[A61K]
2016/0002,702 BLUE COLLAGENASE ASSAYAbandonedJun 29, 15Jan 07, 16[C12Q]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.